← Back to Clinical Trials
Recruiting NCT06491602
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
Trial Parameters
Condition Lupus Nephritis
Sponsor Sohag University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 1 Month
Max Age 18 Years
Start Date 2024-06-24
Completion 2025-06-24
Interventions
renal biobsy
Brief Summary
systemic lupus erthrematosus is an inflamatory and autoimmune condition characterized by multisystem affection and chronic course with unpredictable flares despite potentially afffecting every oragan . kidney involvment are the most common
Eligibility Criteria
Inclusion Criteria: \- aim to include all children fulfilling diagnostic criteria Exclusion Criteria: * children with other rheumatological disorder neonates chidren with other nephrolgy disorder
Related Trials
NCT06491602
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With
View Trial →
NCT06527872
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
View Trial →
NCT06785519
CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis
View Trial →